Skip to content

Investor Centre

Information about our corporate activities for current shareholders and potential investors.

PharmX Technologies Limited is an Australian-owned, publicly listed company. PharmX Technologies shares are listed on the Australian Securities Exchange (ASX) and are traded under the code PHX. The company’s financial year runs from 1 July to 30 June, with half-year results announced in February and the full year results announced in August each year.

Announcements

Change of Company Secretary
November 28, 2024
Chairman’s Address & AGM Presentation
November 26, 2024
Results of Annual General Meeting
November 26, 2024
Notification of cessation of securities – PHX
November 21, 2024
Investor Presentation
October 30, 2024
Notice of Annual General Meeting/Proxy Form
October 25, 2024
Alternate Director
September 9, 2024
Initial Director’s Interest Notice
September 9, 2024
FY24 Results
August 27, 2024
2024 Annual Report and Appendix 4E
August 27, 2024
Investor Presentation
August 27, 2024
Delay of Results Announcement
August 16, 2024
Update on Fred Appeals in Legal Proceedings
August 9, 2024
Letter to Shareholders
August 9, 2024
Trading Halt
August 8, 2024
Update Fred Appeal legal proceedings re Corum Systems/PharmX
August 6, 2024
Ceasing to be a substantial shareholder from AEF
July 31, 2024
Change in substantial shareholding from AEF
July 30, 2024
Notice of Results Announcement 30 June 2024
July 24, 2024
ATO confirms tax implications of return of share capital
July 18, 2024
Update on Fred Appeals in Legal Proceedings
May 30, 2024
Notification regarding unquoted securities – PHX
March 1, 2024
Half Yearly Report and Accounts
February 23, 2024
Loading

Corporate Governance

Audit and Risk Committee Charter
Corporate Governance Statement and Appendix 4G – FY24
Omnibus Equity Plan Rules
Notice of Rights of Members in connection with certain documents – Corporations Act 2001 S110K
Company Constitution
Remuneration and Nomination Committee Charter
Board Charter
Corporate Code of Conduct
Anti-Bribery and Corruption Policy
Market Disclosure Policy
Diversity and Inclusion Policy
Corporate Security Trading Policy
Whistleblower Policy
Conflict of Interest Policy

Annual Reports

2024 Annual Report
2023 Annual Report
2022 Annual Report
2021 Annual Report
2020 Annual Report
2019 Annual Report
Loading